Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.
about
Live attenuated vaccines for invasive Salmonella infectionsVaccines against invasive Salmonella disease: current status and future directionsSalmonella as a vaccine delivery vehicleAttenuated Salmonella Typhimurium lacking the pathogenicity island-2 type 3 secretion system grow to high bacterial numbers inside phagocytes in miceComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardA randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese childrenImmunology of Gut Mucosal VaccinesNovel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesisOptimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters.Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.The delicate balance in genetically engineering live vaccines.Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncESalmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid.Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype TyphiLive recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigenSelection of Salmonella enterica serovar Typhi genes involved during interaction with human macrophages by screening of a transposon mutant libraryPathogenicity islands in bacterial pathogenesisImpact of homologous and non-homologous recombination in the genomic evolution of Escherichia coliLive attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity.Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants.Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infectionSalmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype TyphiEvaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccinesVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.Enteric pathogens as vaccine vectors for foreign antigen deliveryUsing a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancerGenes Required for the Fitness of Salmonella enterica Serovar Typhimurium during Infection of Immunodeficient gp91-/- phox Mice.Use of attenuated bacteria as delivery vectors for DNA vaccines.Identification of salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar typhimurium: implications for rational vaccine design.Type III secretion systems and disease.Salmonella enterica serovar Typhi live vector vaccines finally come of ageProtective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity
P2860
Q27003066-334B4A96-ACF1-407E-AEA4-B884E21ADBDFQ27007088-84E7556E-C796-4D64-8EEE-6A0EE8A91D04Q27011946-EE677F1F-B0F3-48D2-97CF-36644CCD8C46Q27339477-671E6490-A06E-4F22-AF43-E9E017A96B91Q27694492-6606EBE9-8A72-4168-81AB-F7A9A6B14EF2Q28474905-F6467E9A-731B-43CB-BDAA-69236E54026CQ28972559-0ADA0BB4-08E0-4511-94B4-76A1D9DB024CQ30802772-3785660C-AF49-440A-A426-85BC7ADDF583Q33556968-4AB522BE-A859-454F-AF62-AAE4DD938DE4Q33653480-C88B9B28-20B7-437A-B2D9-480B2A3A56C6Q33801051-5FFE6092-C12F-4033-B577-ACEF7C6BE8A4Q33811867-5647FBB9-A7D8-4517-828A-B9ED02CB95DEQ33828828-F281EE76-660A-4B93-AFBF-3F76B7037DAEQ33910337-F0D80AFC-E1E1-47F1-BAB7-B4F340D5B481Q33921859-A3E6E1FC-CCF6-44A8-9AD4-F44FA3E082DCQ34264861-E8E8606B-10A6-4617-AFAC-090EBB25C98DQ34290188-ACBB190E-E27A-4FFF-A58A-189CC81B653EQ34308862-804D7645-EB65-44B8-AE75-208F90854331Q34429033-ACE06530-28C9-4DC2-8E3A-B270391DE52DQ34560345-0BD150E7-968E-4436-8D25-6B3B9FF613BEQ34581467-3EB4BBC3-927B-49E8-8BA7-F76D61DF0E45Q35024060-A1021614-5701-4309-9521-611EDC0A8676Q35059006-1CF16660-39CC-48B3-9499-EAC2ED18812FQ35273267-2591ECF8-BE71-4F7D-9065-61FB70C43E68Q35338804-4C559CA2-4E54-45FD-B45B-DCACFFA30E53Q35689430-F5722782-7752-4D33-916F-BE5C4B85F146Q35773879-3F855991-392B-4D71-818F-E8A7F437EAB5Q35783750-5FDACE69-3972-4ECD-BA83-35D96655DD60Q35887055-5D84F8EA-F3AA-44E1-A770-64C5A162B620Q35896020-4E6598F0-0F40-4999-BDCB-FA7199F6275FQ36105906-50507221-11B2-4BF7-AF51-AD9E97D67BE2Q36281257-3D364828-BAC2-4F5A-812D-A50D67777142Q36593956-19D16A00-7CB1-46EC-BA4B-61FFE19CBFA7Q36728007-5564C496-2D08-4C4F-A91B-F9FDED0FD3EFQ36728805-A05C2F61-F8A3-4601-ADF5-B841B1F7612AQ36790792-3A84470F-F251-415E-B70F-A9BC2204B767Q36969851-BC2D3712-FAEE-4135-B062-721B49000372Q37106127-6BC82205-AFBA-427F-86DB-BF2E1DD09DD8Q37405767-C0D16599-FD42-4893-B603-CCAC5CFE1426Q37429384-878F2863-171D-424F-BDC8-756B3F255E40
P2860
Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Characterization of Salmonella ...... ization of healthy volunteers.
@ast
Characterization of Salmonella ...... ization of healthy volunteers.
@en
Characterization of Salmonella ...... nd 2 type III secretion system
@nl
type
label
Characterization of Salmonella ...... ization of healthy volunteers.
@ast
Characterization of Salmonella ...... ization of healthy volunteers.
@en
Characterization of Salmonella ...... nd 2 type III secretion system
@nl
prefLabel
Characterization of Salmonella ...... ization of healthy volunteers.
@ast
Characterization of Salmonella ...... ization of healthy volunteers.
@en
Characterization of Salmonella ...... nd 2 type III secretion system
@nl
P2093
P2860
P1476
Characterization of Salmonella ...... nization of healthy volunteers
@en
P2093
Amy Sexton
Catherine A Cosgrove
David W Holden
Deborah House
Derek Pickard
Frank R Brennan
George E Griffin
Gordon Dougan
Jaqueline E Shea
Jo Phillimore
P2860
P304
P356
10.1128/IAI.70.7.3457-3467.2002
P407
P577
2002-07-01T00:00:00Z